(19)
(11) EP 1 263 427 A1

(12)

(43) Date of publication:
11.12.2002 Bulletin 2002/50

(21) Application number: 01924195.9

(22) Date of filing: 16.03.2001
(51) International Patent Classification (IPC)7A61K 31/17, A61K 31/35, A61K 31/445, A61K 31/495, C07C 211/56, C07C 241/04, C07C 275/30, C07C 275/32, C07C 275/40, C07C 315/00
(86) International application number:
PCT/US0108/672
(87) International publication number:
WO 0106/8084 (20.09.2001 Gazette 2001/38)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.03.2000 US 189848 P

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
PhiladelphiaPennsylvania 19103 (US)

(72) Inventors:
  • WIDDOWSON, Katherine, L.
    King of Prussia, PA 19406 (US)
  • JIN, Qi
    King of Prussia, PA 19406 (US)

(74) Representative: Quillin, Helen Kaye 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) IL-8 RECEPTOR ANTAGONISTS